The gum is made from bean powder naturally containing a protein that binds to a wide variety of germs, including influenza ...

A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found ...

A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent ...

An early flu season is a powerful reminder of influenza’s unpredictability and potential severity. But with broad access to ...

A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found ...

A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers ...

Scientists at the University of Pennsylvania School of Dental Medicine have created a chewing gum that can neutralize viruses ...

WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current antivirals like Paxlovid. WEHI researchers have developed a drug compound that ...

Looking beyond jabs, sprays or tablets, scientists are thinking outside the box for delivering antiviral medication to ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Comp ...

Each year, seasonal flu sickens about 1 billion people worldwide and causes approximately 290,000 to 650,000 respiratory ...